These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34431881)

  • 1. Unilateral papilledema and peripapillary polypoidal choroidal vasculopathy as the presenting manifestations of intracranial hypertension.
    Matos AMF; Cunha LP; Suzuki ACF; Mello LGM; Preti RC; Zacharias LC; Monteiro MLR
    Arq Bras Oftalmol; 2021; 84(6):598-601. PubMed ID: 34431881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Peripapillary Choroidal Neovascular Membrane in Patients With Idiopathic Intracranial Hypertension.
    Ozgonul C; Moinuddin O; Munie M; Lee MS; Bhatti MT; Landau K; Van Stavern GP; Mackay DD; Lebas M; DeLott LB; Cornblath WT; Besirli CG
    J Neuroophthalmol; 2019 Dec; 39(4):451-457. PubMed ID: 30951011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal Ranibizumab Injection in Peripapillary CNVM Related to Idiopathic Intracranial Hypertension.
    Altan-Yaycioglu R; Canan H; Saygi S
    J Pediatr Ophthalmol Strabismus; 2017 Apr; 54():e27-e30. PubMed ID: 28453165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INTRAVITREAL AFLIBERCEPT IN THE TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY ASSOCIATED WITH MORNING GLORY SYNDROME.
    Iovino C; Fossarello M; Peiretti E
    Retin Cases Brief Rep; 2020; 14(3):278-281. PubMed ID: 29324624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab in the treatment of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension.
    Lee IJ; Maccheron LJ; Kwan AS
    J Neuroophthalmol; 2013 Jun; 33(2):155-7. PubMed ID: 23235432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful management of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension with intravitreal ranibizumab.
    Kumar N; Tigari B; Dogra M; Singh R
    Indian J Ophthalmol; 2018 Sep; 66(9):1358-1360. PubMed ID: 30127172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results.
    Kokame GT; Lai JC; Wee R; Yanagihara R; Shantha JG; Ayabe J; Hirai K
    BMC Ophthalmol; 2016 Jul; 16():127. PubMed ID: 27465105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy.
    Kim H; Lee SC; Kwon KY; Lee JH; Koh HJ; Byeon SH; Kim SS; Kim M; Lee CS
    Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1497-1503. PubMed ID: 26626772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optic disk melanocytoma associated with polypoidal choroidal vasculopathy lesions, after combination treatment of photodynamic therapy and intavitreal aflibercept (Eylea), a case report.
    Rouvas A; Gouliopoulos NS; Moschos MM; Theodossiadis P
    BMC Ophthalmol; 2018 Oct; 18(1):267. PubMed ID: 30309335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year outcomes of intravitreal bevacizumab (avastin) therapy for polypoidal choroidal vasculopathy.
    Cheng CK; Peng CH; Chang CK; Hu CC; Chen LJ
    Retina; 2011 May; 31(5):846-56. PubMed ID: 21317837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy.
    Sato T; Kishi S; Matsumoto H; Mukai R
    Am J Ophthalmol; 2010 Jun; 149(6):947-954.e1. PubMed ID: 20346441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal Manifestations of Idiopathic Intracranial Hypertension.
    Nichani P; Micieli JA
    Ophthalmol Retina; 2021 May; 5(5):429-437. PubMed ID: 32860958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term effectiveness of intravitreal bevacizumab vs. ranibizumab injections for patients with polypoidal choroidal vasculopathy.
    Cho HJ; Baek JS; Lee DW; Kim CG; Kim JW
    Korean J Ophthalmol; 2012 Jun; 26(3):157-62. PubMed ID: 22670070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy.
    Wakabayashi T; Gomi F; Sawa M; Tsujikawa M; Nishida K
    Br J Ophthalmol; 2012 Mar; 96(3):394-9. PubMed ID: 21719568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined reduced fluence photodynamic therapy and intravitreal ranibizumab for polypoidal choroidal vasculopathy.
    Ricci F; Calabrese A; Regine F; Missiroli F; Ciardella AP
    Retina; 2012 Jul; 32(7):1280-8. PubMed ID: 22218148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to pseudotumor cerebri.
    Jamerson SC; Arunagiri G; Ellis BD; Leys MJ
    Int Ophthalmol; 2009 Jun; 29(3):183-5. PubMed ID: 18196206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripapillary Choroidal Thickness Change of Polypoidal Choroidal Vasculopathy after Anti-vascular Endothelial Growth Factor.
    Lee KH; Kim SH; Lee JM; Kang EC; Koh HJ
    Korean J Ophthalmol; 2017 Oct; 31(5):431-438. PubMed ID: 28994269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete regression of branching vascular network in polypoidal choroidal vasculopathy by ranibizumab and photodynamic therapy, two case reports.
    Iesato Y; Tanaka M; Murata M; Kitahara J; Hirano T; Kurenuma T; Yoshida N; Murata T
    BMC Ophthalmol; 2018 Nov; 18(1):284. PubMed ID: 30390650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripapillary choroidal neovascular membrane in a teenage boy: presenting feature of idiopathic intracranial hypertension and resolution with intravitreal bevacizumab.
    Belliveau MJ; Xing L; Almeida DR; Gale JS; ten Hove MW
    J Neuroophthalmol; 2013 Mar; 33(1):48-50. PubMed ID: 23403388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-vascular endothelial growth factor monotherapy in the treatment of submacular hemorrhage secondary to polypoidal choroidal vasculopathy.
    Cho HJ; Koh KM; Kim HS; Lee TG; Kim CG; Kim JW
    Am J Ophthalmol; 2013 Sep; 156(3):524-531.e1. PubMed ID: 23769197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.